Genotyping cell-free tumor DNA in the blood to detect residual disease and drug resistance

Research output: Contribution to journalArticlepeer-review

Abstract

DNA fragments released from cancer cells into the blood can be used to generate molecular profiles of tumors. Non-invasive 'liquid biopsies' can be used to monitor minimal residual disease and detect the emergence of drug resistance.

Original languageEnglish
JournalGenome Biology
DOIs
Publication statusAccepted/In press - Aug 30 2014

ASJC Scopus subject areas

  • Cell Biology
  • Ecology, Evolution, Behavior and Systematics
  • Genetics

Fingerprint Dive into the research topics of 'Genotyping cell-free tumor DNA in the blood to detect residual disease and drug resistance'. Together they form a unique fingerprint.

Cite this